Lisa Weldon, NP
Adult Health · Valdosta, GANPI 1538470851
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 256 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 41 manufacturers, the largest accounting for just 10.2% — the pattern of someone who eats at a lot of different presentations. Among adult health clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 256 payments — averaging $20.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$539
- UCB, Inc.$486
- Abbott$428
- Dexcom, Inc.$311
- Medtronic$307
- Boehringer Ingelheim$291
- plus $3K from 35 others
What the payments were for
- Food & beverage$5,23699%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 26 | $539 |
| UCB, Inc. | 22 | $486 |
| Abbott | 31 | $428 |
| Dexcom, Inc. | 15 | $311 |
| Medtronic | 12 | $307 |
| Boehringer Ingelheim | 13 | $291 |
| Tandem Diabetes Care, Inc. | 12 | $260 |
| Novo Nordisk | 17 | $254 |
| Bayer | 13 | $243 |
| AstraZeneca(2 entities) | 9 | $172 |
| Zealand Pharma US, Inc. | 7 | $156 |
| Insulet Corporation | 7 | $149 |
| Jazz Pharmaceuticals Inc. | 4 | $148 |
| Neurelis, Inc. | 6 | $129 |
| CSL Behring | 4 | $122 |
| Pfizer | 6 | $120 |
| Ipsen Biopharmaceuticals, Inc | 6 | $118 |
| Argenx US, Inc. | 3 | $98 |
| Sanofi-aventis U.S. LLC | 4 | $85 |
| Xeris Pharmaceuticals, Inc. | 4 | $79 |
| Catalyst Pharmaceuticals, Inc. | 3 | $72 |
| Grifols USA, LLC | 3 | $61 |
| Alnylam Pharmaceuticals Inc. | 1 | $58 |
| Teva Pharmaceuticals USA, Inc. | 3 | $51 |
| Kyowa Kirin, Inc. | 2 | $43 |
| Amarin Pharma, Inc. | 2 | $41 |
| Eisai Inc. | 2 | $39 |
| Mannkind Corporation | 2 | $38 |
| Genentech USA, Inc. | 2 | $38 |
| Amgen | 2 | $38 |
| Coloplast | 2 | $34 |
| Merz Pharmaceuticals, LLC | 1 | $34 |
| AbbVie | 2 | $34 |
| ANI Pharmaceuticals, Inc. | 1 | $33 |
| MDD US Operations, LLC | 1 | $31 |
| Blue Earth Diagnostics | 1 | $28 |
| Lundbeck LLC | 1 | $28 |
| SK Life Science, Inc. | 1 | $28 |
| Bard Access Systems, Inc. | 1 | $26 |
| Lifescan, Inc. | 1 | $19 |
| Harmony Biosciences LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MINIMED 780G$123
How this compares
$5,283 in reported general payments places this provider in the 90th percentile of 577 adult health providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 336 | $383,663 |
| MounjaroTirzepatide | 200 | $250,279 |
| FarxigaDapagliflozin Propanediol | 220 | $167,193 |
| TrulicityDulaglutide | 121 | $148,601 |
| JardianceEmpagliflozin | 153 | $124,018 |
| Tresiba Flextouch U-200Insulin Degludec | 76 | $68,101 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 41 | $67,636 |
| Tresiba Flextouch U-100Insulin Degludec | 89 | $60,602 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 33 | $27,536 |
| VascepaIcosapent Ethyl | 56 | $26,489 |
| Humalog Kwikpen U-100Insulin Lispro | 58 | $25,180 |
| Humalog Kwikpen U-200Insulin Lispro | 11 | $21,612 |
| JanuviaSitagliptin Phosphate | 22 | $20,844 |
| Praluent PenAlirocumab | 33 | $18,631 |
| Novolog FlexpenInsulin Aspart | 51 | $16,138 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Humalog, Insulin Lispro | $539 | $416,708426 claims |
| Novo NordiskOzempic, Novolog | $254 | $389,142349 claims |
| AstraZenecaFarxiga | $172 | $167,193220 claims |
| Boehringer IngelheimJardiance | $291 | $124,018153 claims |
| AbbVieSynthroid | $34 | $3,27855 claims |
| Sanofi-aventis U.S. LLCLantus | $85 | $1,58517 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 577 adult health providers in Georgia.
Other adult health in Valdosta
- Dakshaben ColemanValdosta$9K
- Abbey VandermeidValdosta$8K
- Joshua BatsonValdosta$8K
- Christine BrownValdosta$7K
- Patricia KeeganAtlanta$224K
- Diane WirthAtlanta$132K
- Barbara WeberAtlanta$74K
- Terry HackworthAtlanta$49K
- Jenny DicksonCumming$39K
- Rachel NejemLawrenceville$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.